文献速递血液净化与透析慢性肾脏病水电解质与酸碱

腹膜透析患者长期大剂量维生素C摄入相关草酸盐沉积症

Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
PubMed 文献 · Am J Kidney Dis · 2019-03-22

本文报告一例维持性腹膜透析患者因长期每日服用高达4g维生素C导致全身性草酸盐沉积症,累及眼和关节。患者血浆草酸盐显著升高至187 μmol/L,停用维生素C并转为每日血液透析后血浆草酸盐下降但仍高于透析患者典型水平,视觉稳定、关节症状改善。提示晚期慢性肾脏病尤其腹膜透析患者应警惕大剂量维生素C风险。

要点

  • 晚期CKD尤其腹膜透析患者长期大剂量维生素C可致全身性草酸盐沉积症。
  • 表现包括关节痛加重、视力下降、增殖性视网膜病变和草酸钙结晶。
  • 停用维生素C并强化透析可降低血浆草酸盐并改善症状。

核心结论

  • 晚期慢性肾脏病尤其腹膜透析患者长期大剂量维生素C摄入可导致全身性草酸盐沉积症。

研究设计与样本

  • 单例病例报告:76岁女性,常染色体显性多囊肾病,维持性腹膜透析。

主要发现

  • 患者表现为关节痛加重和视力下降,眼科检查示增殖性视网膜病变和草酸钙结晶。
  • 血浆草酸盐显著升高至187 μmol/L(参考范围<1.7 μmol/L),尿草酸盐-肌酐比值高(0.18 mg/mg)。
  • 停用维生素C并转为每日血液透析2周后,透析前血浆草酸盐降至30-53 μmol/L,但仍高于透析患者典型水平。

临床怎么用

  • 对晚期CKD尤其腹膜透析患者应询问大剂量维生素C使用史。
  • 怀疑草酸盐沉积症时应检测血浆草酸盐水平。
  • 停用维生素C并强化透析可能改善症状和降低血浆草酸盐。

局限性

  • 单例病例报告,因果关系和时间关联需谨慎解读。
  • 未提供尿草酸盐-肌酐比值的参考范围。
  • 未报告长期随访结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report a case of systemic oxalosis involving the eyes and joints due to long-term use of high-dose vitamin C in a patient receiving maintenance peritoneal dialysis (PD). This 76-year-old woman with autosomal dominant polycystic kidney disease underwent living unrelated kidney transplantation 10 years earlier. The transplant failed 6 months before presentation, and she initiated hemodialysis therapy before transitioning to PD therapy 4 months later. During the month before presentation, the patient noted worsening arthralgias and decreased vision. Ophthalmologic examination revealed proliferative retinopathy and calcium oxalate crystals. Plasma oxalate level was markedly elevated at 187 (reference range, <1.7) μmol/L, and urine oxalate-creatinine ratio was high (0.18mg/mg). The patient reported taking up to 4g of vitamin C per day for several years. Workup for causes of primary and secondary hyperoxaluria was otherwise negative. Vitamin C use was discontinued, and the patient transitioned to daily hemodialysis for 2 weeks. Plasma oxalate level before the dialysis session decreased but remained higher (30-53μmol/L) than typical for dialysis patients. Upon discharge, the patient remained on thrice-weekly hemodialysis therapy with stabilized vision and improved joint symptoms. This case highlights the risk of high-dose vitamin C use in patients with advanced chronic kidney disease, especially when maintained on PD therapy.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. D'Costa MR, Winkler NS, Milliner DS, et al. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient. Am J Kidney Dis. 2019. PMID: 30910370. doi:10.1053/j.ajkd.2019.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。